Research Study
View Full Study →
Chronic palmitoylethanolamide administration via slow-release subcutaneous pellets promotes neuroprotection and mitigates neuroinflammation in the Tg2576 mouse model of Alzheimer's disease.
Citation
Tortolani D., Decandia D., Giacovazzo G., Scipioni L., Panuccio A. et al. (2025). Chronic palmitoylethanolamide administration via slow-release subcutaneous pellets promotes neuroprotection and mitigates neuroinflammation in the Tg2576 mouse model of Alzheimer's disease.. Front Cell Neurosci. DOI: 10.3389/fncel.2025.1571428
Abstract
Abstract not available. See citation for source.
Disclaimer: This research summary is for educational purposes only. Always consult with a healthcare professional before making decisions based on scientific research.